Iran - Women's share of population ages 15+ living with HIV (%)

Women's share of population ages 15+ living with HIV (%) in Iran was 27.40 as of 2020. Its highest value over the past 30 years was 68.90 in 1990, while its lowest value was 14.50 in 2007.

Definition: Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.

Source: UNAIDS estimates.

See also:

Year Value
1990 68.90
1991 63.40
1992 57.20
1993 50.90
1994 46.00
1995 44.50
1996 43.20
1997 40.30
1998 36.50
1999 32.10
2000 27.70
2001 23.80
2002 20.50
2003 18.00
2004 16.30
2005 15.30
2006 14.70
2007 14.50
2008 14.70
2009 15.10
2010 15.60
2011 16.30
2012 17.20
2013 18.10
2014 19.20
2015 20.50
2016 21.80
2017 23.20
2018 24.60
2019 26.00
2020 27.40

Limitations and Exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information.

Statistical Concept and Methodology: HIV prevalence rates reflect the rate of HIV infection in each country's population. Low national prevalence rates can be misleading, however. They often disguise epidemics that are initially concentrated in certain localities or population groups and threaten to spill over into the wider population. In many developing countries most new infections occur in young adults, with young women especially vulnerable. Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. The models, which are routinely updated, track the course of HIV epidemics and their impact, making full use of information in HIV prevalence trends from surveillance data as well as survey data. The models take into account reduced infectivity among people receiving antiretroviral therapy (which is having a larger impact on HIV prevalence and allowing HIV-positive people to live longer) and allow for changes in urbanization over time in generalized epidemics. The estimates include plausibility bounds, which reflect the certainty associated with each of the estimates.

Aggregation method: Weighted average

Periodicity: Annual

Classification

Topic: Health Indicators

Sub-Topic: Risk factors